# Evinacumab (Genetical Recombination) I.V. Infusion 345mg (エヴキーザ点滴静注液３４５ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 2189404A1020). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 2189404A1020
- **Product name (Japanese):** エヴキーザ点滴静注液３４５ｍｇ
- **English title:** Evinacumab (Genetical Recombination) I.V. Infusion 345mg
- **Active ingredient:** エビナクマブ（遺伝子組換え）
- **Active ingredient (INN):** Evinacumab (Genetical Recombination)
- **Strength / unit:** ３４５ｍｇ２．３ｍＬ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 21 Cardiovascular agents (循環器官用薬) › 218 Antihyperlipidemics (高脂血症用剤)
- **Manufacturer:** Ｕｌｔｒａｇｅｎｙｘ Ｊａｐａｎ
- **NHI price (reference only):** JPY 1409928 per ３４５ｍｇ２．３ｍＬ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/2189404A1020
- **JSON:** https://www.nifujipharma.com/api/drugs/2189404A1020

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Evinacumab%20(Genetical%20Recombination)%20I.V.%20Infusion%20345mg%20(%E3%82%A8%E3%83%B4%E3%82%AD%E3%83%BC%E3%82%B6%E7%82%B9%E6%BB%B4%E9%9D%99%E6%B3%A8%E6%B6%B2%EF%BC%93%EF%BC%94%EF%BC%95%EF%BD%8D%EF%BD%87)%20%2F%20YJ%202189404A1020#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.